ARONAMIN GOLD

Manufacturer
OASIS TRADING
Effective date
2018-12-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:57:36

Label at a glance#

ProductARONAMIN GOLD
Active ingredientRIBOFLAVIN TETRABUTYRATE, FURSULTIAMINE, HYDROXOCOBALAMIN ACETATE, .ALPHA.-TOCOPHEROL ACETATE, ASCORBIC ACID
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Fursultiamine(Active vitamin B1) 50.0mg
Riboflavin tetrabutyrate(Active vitamin B2) 2.5mg
Pyridoxal phosphate(Active vitamin B6) 2.5mg
Hydroxocobalamin acetate(Active vitamin B12) 5.22μg
Ascorbic acid(Vitamin C) 70mg
Tocopheryl acetate(Vitamin E) 20.0mg

OTC - PURPOSE SECTION

Vitamines, Mineral & nutrients

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

INDICATIONS & USAGE SECTION

Adults: take 1 tablet twice a day.

WARNINGS SECTION

1) Do not take this medicine.

(1) Patients with hypersensitivity reactions to NSAIDs and the components contained in NSAIDs

(2) Infants under three months of age

(3) Because this drug contains lactose, patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption Do not administer.

2) Do not take the following medicine while taking this medicine.

(1) levodopa

3) Consult a doctor, dentist or pharmacist before taking this medicine.

(1) Patients receiving medical treatment

(2) patients with hyperoxaluria (excessive urinary excretion of urine)

(3) Pregnant women and possibly pregnant women, lactating women, premature infants, infants

(4) Patients with gout or kidney stones

4) Stop taking this drug immediately and consult a doctor, dentist, or pharmacist if you: Whenever possible, bring this attached document with you.

(1) If you have any of the following symptoms

Stomach discomfort, diarrhea, constipation, rash, fever, nausea, vomiting, dilated stool, stomatitis (mouth salt), anorexia, abdominal bloating

(2) Administration of this drug may result in faster or more frequent menstruation, and bleeding may last for a long time.

(3) The risk of thrombosis may be increased if a woman taking an oral contraceptive containing estrogen or a patient with thrombotic placenta is taking vitamin E.

(4) Long-term administration of high doses may result in resistance.

(5) Prolonged use of pyridoxine at a dose of 500 mg to 2 g / day may result in neuropathy or neuropathy (functional disorder or pathologic changes) in the peripheral nervous system.

(6) Hematologic adverse events may occur when vitamin B12 is administered at a dose of 10 μg or more per day in patients with insufficient folic acid.

5) Other Precautions for Taking

(1) Keep the prescribed dosage and dosage.

(2) it may interfere with the detection of blood glucose during various urine tests

(3) The urine may turn yellow, which may affect the clinical examination

6) Storage Precautions

(1) Keep out of the reach of children.

(2) Avoid direct sunlight. Store in a cool, dry place.

(3) To prevent misuse (misuse) and to preserve quality, please do not put in another container.

INACTIVE INGREDIENT SECTION

Microcrystalline Cellulose, Magnesium Stearate, Crospovidone, Copovidone, Colloidal Silicon Dioxide, OY-25014, OY-S-29019

DOSAGE & ADMINISTRATION SECTION

For oral use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ASCORBIC ACID Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
HYDROXOCOBALAMIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72689-0024-12020-01-31C16284748780-19d75b9d0-4069-f424-e053-dadaa90a57ce7cceda8a-2bfe-b286-e053-2a91aa0a0c4b

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72689-0024-1ARONAMIN GOLD100 in 1 BLISTER PACKTABLET, FILM COATED1001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72689-0024ARONAMIN GOLD (FURSULTIAMINE, RIBOFLAVIN TETRABUTYRATE, PYRIDOXAL PHOSPHATE, HYDROXOCOBALAMIN ACETATE, ASCORBIC ACID, TOCOPHERYL ACETATE) TABLET, FILM COATED [OASIS TRADING]1Legacy NDC, 1 package rows20181213_7cceda8a-2bfe-b286-e053-2a91aa0a0c4b.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72689-002472689-0024-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
7cceda8a-2bff-b286-e053-2a91aa0a0c4b7cceda8a-2bfe-b286-e053-2a91aa0a0c4b2018-12-12WarningsExact identifier
spl id: 7cceda8a-2bff-b286-e053-2a91aa0a0c4b
spl set id: 7cceda8a-2bfe-b286-e053-2a91aa0a0c4b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.